Cencora, Inc. (NYSE:COR) Shares Acquired by Financial Counselors Inc.

Financial Counselors Inc. increased its stake in Cencora, Inc. (NYSE:COR) by 20.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,284 shares of the company’s stock after acquiring an additional 216 shares during the period. Financial Counselors Inc.’s holdings in Cencora were worth $289,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. B. Riley Wealth Advisors Inc. purchased a new position in Cencora in the first quarter worth approximately $411,000. LRI Investments LLC acquired a new stake in shares of Cencora in the 1st quarter valued at $31,000. Cetera Investment Advisers purchased a new stake in shares of Cencora during the 1st quarter worth $16,625,000. Cetera Advisors LLC acquired a new position in shares of Cencora during the first quarter worth $2,091,000. Finally, EverSource Wealth Advisors LLC purchased a new position in Cencora in the first quarter valued at $325,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cencora

In related news, Chairman Steven H. Collis sold 21,509 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $242.16, for a total transaction of $5,208,619.44. Following the sale, the chairman now directly owns 306,752 shares of the company’s stock, valued at approximately $74,283,064.32. This represents a 6.55 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders have sold 93,018 shares of company stock worth $22,478,942 in the last ninety days. 15.80% of the stock is owned by insiders.

Analyst Ratings Changes

COR has been the topic of several research analyst reports. Bank of America reissued a “neutral” rating and set a $245.00 target price (down previously from $275.00) on shares of Cencora in a research report on Wednesday, September 18th. Robert W. Baird raised their price objective on shares of Cencora from $287.00 to $292.00 and gave the stock an “outperform” rating in a report on Thursday, November 7th. UBS Group increased their target price on shares of Cencora from $275.00 to $285.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Evercore ISI boosted their price target on shares of Cencora from $250.00 to $285.00 and gave the company an “outperform” rating in a research report on Thursday, November 7th. Finally, StockNews.com downgraded shares of Cencora from a “strong-buy” rating to a “buy” rating in a research note on Friday, September 20th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $271.20.

Cencora Stock Up 0.7 %

Shares of NYSE:COR opened at $251.55 on Friday. The company has a market capitalization of $49.57 billion, a price-to-earnings ratio of 33.50, a price-to-earnings-growth ratio of 1.66 and a beta of 0.44. The company has a 50 day moving average of $234.91 and a two-hundred day moving average of $232.53. Cencora, Inc. has a 52-week low of $195.83 and a 52-week high of $253.27. The company has a quick ratio of 0.53, a current ratio of 0.88 and a debt-to-equity ratio of 4.84.

Cencora Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were issued a $0.55 dividend. The ex-dividend date was Friday, November 15th. This is a boost from Cencora’s previous quarterly dividend of $0.51. This represents a $2.20 annualized dividend and a yield of 0.87%. Cencora’s dividend payout ratio is currently 29.29%.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.